Oyler John

Chief Executive Officer, DirectorBeOne Medicines Ltd. (ONC) · full profile →Form 4 · filed Jul 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$44.6M
Net Open-Market Flow
-$44.6M
Transactions
10
8 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 14, 2026Sell(S)4K$303.07$1.3M8K
Jul 14, 2026Sell(S)8K$303.93$2.5M0
Jul 14, 2026Option exercise(M)97K$36.90$3.6M97K
Jul 14, 2026Option exercise(M)36K$100.04$3.6M134K
Jul 14, 2026Sell(S)39K$305.02$11.9M95K
Jul 14, 2026Sell(S)46K$306.21$14.1M49K
Jul 14, 2026Sell(S)41K$306.93$12.5M8K
Jul 14, 2026Sell(S)8K$307.57$2.4M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 14, 2026Option exercise(M)1.3M$00
Jul 14, 2026Option exercise(M)472K$0463K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001042047-26-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.